Photodynamic therapy of cutaneous epithelial malignancies. An evidence-based review;Photodynamische therapie bei epithelialen hauttumoren. Evidenzbasierte datenlage

Hautarzt

Volumn 58, Issue 7, 2007, Pages 577-584

  Sidoroff, A ^a  

^a Universitatsklinik fuer Dermatologie und Venerologie Innsbruck   (Austria)

Author keywords

Actinic keratoses; Basal cell carcinoma; Bowen's disease; Non melanoma skin cancer; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DICLOFENAC; FLUOROURACIL; IMIQUIMOD; PLACEBO;

BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CHEMOTHERAPY; CANCER THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CRYOTHERAPY; CURETTAGE; ELECTROSURGERY; ESTHETICS; EVIDENCE BASED MEDICINE; HUMAN; HYPERKERATOSIS; INTERMETHOD COMPARISON; LASER; LASER SURGERY; NON INVASIVE PROCEDURE; PHOTODYNAMIC THERAPY; REVIEW; SKIN CANCER; SKIN EPITHELIUM; TUMOR VOLUME; ULTRAVIOLET RADIATION;

BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CRYOTHERAPY; EVIDENCE-BASED MEDICINE; HUMANS; KERATOSIS; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; PATIENT ACCEPTANCE OF HEALTH CARE; PHOTOCHEMOTHERAPY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN NEOPLASMS; SUNLIGHT; TIME FACTORS;

EID: 34447638660     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1348-3     Document Type: Review

References (41)

1. Alexiades-Armenakas MR, Geronemus RG (2003) Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139(10): 1313-1320
2. Basset-Seguin N, Ibbotson S, Emtestam L et al. (2004) MAL-PDT vs. cryotherapy in primary sBCC: results of a 36 months follow up. J Eur Acad Dermatol Venerol 18 [Suppl 2]: 412
3. Basset-Seguin N, Ibbotson S, Emtestam L, et al. (2005) MAL-PDT vs. cryotherapy in primary sBCC: results of a 48-months follow up. J Eur Acad Dermatol Venerol 18 [Suppl 2]: 412
4. Braathen LR, Szeimies RM, Basset-Seguin N et al. (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56(1): 125-143
5. Calzavara-Pinton PG (1995) Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 29(1): 53-57
6. Dragieva G, Prinz BM, Hafner J et al. (2004) A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 151(1): 196-200
7. Fijan S, Honigsmann H, Ortel B (1995) Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 133(2): 282-288
8. Fink-Puches R, Soyer HP, Hofer A et al. (1998) Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 134(7): 821-826
9. Foley P, Freeman M, Siller G et al. (2003) A phase III randomized study comparing photodynamic therapy using Metvix® or placebo cream in nodular basal cell carcinoma (BCC). Australas J Dermatol 44(3): A5
10. Freeman M, Vinciullo C, Francis D et al. (2003) A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14(2): 99-106
11. Gold MH, Nestor MS (2006) Current treatments of actinic keratosis. J Drugs Dermatol 5 [2 Suppl]: 17-25
12. Goldman M, Atkin D (2003) ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy. J Cosmet Laser Ther 5(2): 107-110
13. Haller JC, Cairnduff F, Slack G et al. (2000) Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143(6): 1270-1275
14. Horn M, Wolf P, Wulf HC et al. (2003) Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149(6): 1242-1249
15. Jeffes EW (2002) Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J Dermatolog Treat 13 [Suppl 1]: S19-23
16. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6(1-2): 143-148
17. Kurwa HA, Yong-Gee SA, Seed PT et al. (1999) A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 41 (3 Pt 1): 414-418
18. Lehmann P (2007) Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol (in press)
19. Morton C, Campbell S, Gupta G et al. (2006) Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 155(5): 1029-1036
20. Morton C, Horn M, Leman J et al. (2006) Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 142(6): 729-735
21. Morton CA, Brown SB, Collins S et al. (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4): 552-567
22. Morton CA, Whitehurst C, Moore JV, MacKie RM (2000) Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143(4): 767-772
23. Morton CA, Whitehurst C, Moseley H et al. (1996) Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135(5): 766-771
24. Pariser DM, Lowe NJ, Stewart DM et al. (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2): 227-232
25. Piacquadio DJ, Chen DM, Farber HF et al. (2004) Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 140(1): 41-46
26. Rhodes LE, de Rie M, Enstrom Y et al. (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140(1): 17-23
27. Rhodes LE, de Rie M, Enstrom Y et al. (2006) A randomized European comparison of MAL-PDT and excision surgery in nodular basal cell carcinoma: Results from a 60 month follow-up study. Poster presented at the 3rd Meeting of the European Association of Dermato-Oncology Rome, June 23-35 2006. J Invest Dermatol 126 [Suppl 2]: 534
28. Salim A, Leman JA, McColl JH et al. (2003) Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148(3): 539-343
29. Smith S, Piacquadio D, Morhenn V et al. (2003) Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol 2(6): 629-635
30. Soler AM, Warloe T, Berner A, Giercksky KE (2001) A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145(3): 467-471
31. Soler AM, Warloe T, Tausjo J, Berner A (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 79(3): 204-206
32. Svanberg K, Andersson T, Killander D et al. (1994) Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 130(6): 743-751
33. Szeimies RM, Karrer S, Radakovic-Fijan S et al. (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47(2): 258-262
34. Szeimies RM, Morton CA, Sidoroff A, Braathen LR (2005) Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 85(6): 483-490
35. Tarstedt M, Rosdahl I, Berne B et al. (2005) A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 85(5): 424-428
36. Thissen MR, Schroeter CA, Neumann HA (2000) Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 142(2): 338-339
37. Tope WD, Menter A, El-Azhary RA et al. (2004) Comparison of topical methyl aminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular BCC. J Eur Acad Dermatol Venerol 18 [Suppl 2]: 413-414
38. Touma D, Yaar M, Whitehead S et al. (2004) A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140(1): 33-40
39. Vinciullo C, Elliott T, Francis D et al. (2005) Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 152(4): 765-772
40. Wang I, Bendsoe N, Klinteberg CA et al. (2001) Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144(4): 832-840
41. Wennberg AM, Lindholm LE, Alpsten M, Larko O (1996) Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 288(10): 561-564